An antiviral chewing gum to reduce influenza and herpes simplex virus transmission

Published on April 4, 2025

Low vaccination rates for influenza viruses and the lack of an HSV vaccine underscore the need for a new approach to reduce viral transmission. Researchers have now used a clinical-grade antiviral chewing gum to substantially reduce viral loads of two herpes simplex viruses and two influenza A strains in experimental models.

Read Full Article (External Site)